Last updated on January 2017

A Phase 1/2 Study to Assess MultiStem Therapy in Acute Respiratory Distress Syndrome


Brief description of study

A study to examine the safety (and potential efficacy) of the adult stem cell investigational product, MultiStem, in adults who have Acute Respiratory Distress Syndrome (ARDS). The primary hypothesis is that MultiStem will be safe in ARDS patients.

Clinical Study Identifier: NCT02611609

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Anthony Ting, PhD

University Hospitals - Cleveland Medical Center
Cleveland, OH United States
  Connect »

Anthony Ting, PhD

Hospital of the University of Pennsylvania
Philadelphia, PA United States
  Connect »

Anthony Ting, PhD

University of Pittsburgh Medical Center
Pittsburgh, PA United States
  Connect »

Anthony Ting, PhD

Queen Elizabeth Hospital
Birmingham, United Kingdom
  Connect »

Anthony Ting, PhD

Addenbrooke's Hospital
Cambridge, United Kingdom
  Connect »

Anthony Ting, PhD

University College London Hospital
London, United Kingdom
  Connect »

Anthony Ting, PhD

St. Georges Hospital
London, United Kingdom
  Connect »

Anthony Ting, PhD

Manchester Royal Infirmary
Manchester, United Kingdom
  Connect »

Anthony Ting, PhD

Wythenshawe Hospital
Manchester, United Kingdom
  Connect »

Anthony Ting, PhD

John Radcliffe Hospital
Oxford, United Kingdom
  Connect »